nodes	percent_of_prediction	percent_of_DWPC	metapath
Pipotiazine—CYP2C19—epilepsy syndrome	0.0835	0.322	CbGaD
Pipotiazine—HTR2A—epilepsy syndrome	0.0677	0.261	CbGaD
Pipotiazine—CYP2D6—epilepsy syndrome	0.0619	0.239	CbGaD
Pipotiazine—ALB—epilepsy syndrome	0.0463	0.179	CbGaD
Pipotiazine—Ethopropazine—Carbamazepine—epilepsy syndrome	0.0249	0.0836	CrCrCtD
Pipotiazine—Imipramine—Carbamazepine—epilepsy syndrome	0.0223	0.0749	CrCrCtD
Pipotiazine—Methdilazine—Carbamazepine—epilepsy syndrome	0.0219	0.0734	CrCrCtD
Pipotiazine—Clomipramine—Clobazam—epilepsy syndrome	0.021	0.0706	CrCrCtD
Pipotiazine—Promethazine—Carbamazepine—epilepsy syndrome	0.0207	0.0693	CrCrCtD
Pipotiazine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0206	0.069	CrCrCtD
Pipotiazine—Alimemazine—Carbamazepine—epilepsy syndrome	0.0203	0.068	CrCrCtD
Pipotiazine—Methdilazine—Oxcarbazepine—epilepsy syndrome	0.0202	0.0676	CrCrCtD
Pipotiazine—ALB—Oxcarbazepine—epilepsy syndrome	0.0201	0.0582	CbGbCtD
Pipotiazine—Clomipramine—Diazepam—epilepsy syndrome	0.0196	0.0656	CrCrCtD
Pipotiazine—Promethazine—Oxcarbazepine—epilepsy syndrome	0.019	0.0638	CrCrCtD
Pipotiazine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0187	0.0627	CrCrCtD
Pipotiazine—Chlorpromazine—Clobazam—epilepsy syndrome	0.0186	0.0624	CrCrCtD
Pipotiazine—ALB—Fosphenytoin—epilepsy syndrome	0.0175	0.0508	CbGbCtD
Pipotiazine—Promazine—Carbamazepine—epilepsy syndrome	0.0175	0.0586	CrCrCtD
Pipotiazine—SLC22A1—Midazolam—epilepsy syndrome	0.017	0.0492	CbGbCtD
Pipotiazine—Prochlorperazine—Clobazam—epilepsy syndrome	0.0167	0.0561	CrCrCtD
Pipotiazine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0161	0.054	CrCrCtD
Pipotiazine—ALB—Clonazepam—epilepsy syndrome	0.0159	0.046	CbGbCtD
Pipotiazine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.013	0.0377	CbGbCtD
Pipotiazine—ALB—Rufinamide—epilepsy syndrome	0.0129	0.0375	CbGbCtD
Pipotiazine—CYP2C19—Trimethadione—epilepsy syndrome	0.0121	0.0351	CbGbCtD
Pipotiazine—CYP2C19—Felbamate—epilepsy syndrome	0.0121	0.0351	CbGbCtD
Pipotiazine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0114	0.033	CbGbCtD
Pipotiazine—ALB—Phenytoin—epilepsy syndrome	0.0113	0.0328	CbGbCtD
Pipotiazine—ALB—Propofol—epilepsy syndrome	0.0105	0.0305	CbGbCtD
Pipotiazine—CYP2C19—Clobazam—epilepsy syndrome	0.00986	0.0286	CbGbCtD
Pipotiazine—ALB—Diazepam—epilepsy syndrome	0.00955	0.0277	CbGbCtD
Pipotiazine—CYP2C19—Carbamazepine—epilepsy syndrome	0.00817	0.0237	CbGbCtD
Pipotiazine—CYP2C19—Primidone—epilepsy syndrome	0.00763	0.0221	CbGbCtD
Pipotiazine—CYP1A2—Carbamazepine—epilepsy syndrome	0.00754	0.0218	CbGbCtD
Pipotiazine—CYP2C19—Phenytoin—epilepsy syndrome	0.00733	0.0212	CbGbCtD
Pipotiazine—CYP1A2—Primidone—epilepsy syndrome	0.00704	0.0204	CbGbCtD
Pipotiazine—CYP2C19—Propofol—epilepsy syndrome	0.00683	0.0198	CbGbCtD
Pipotiazine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00653	0.0189	CbGbCtD
Pipotiazine—CYP1A2—Propofol—epilepsy syndrome	0.00631	0.0183	CbGbCtD
Pipotiazine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00629	0.0182	CbGbCtD
Pipotiazine—CYP2C19—Diazepam—epilepsy syndrome	0.00619	0.0179	CbGbCtD
Pipotiazine—CYP2C19—Zonisamide—epilepsy syndrome	0.00604	0.0175	CbGbCtD
Pipotiazine—CYP1A2—Phenobarbital—epilepsy syndrome	0.00603	0.0175	CbGbCtD
Pipotiazine—CYP3A4—Trimethadione—epilepsy syndrome	0.00585	0.0169	CbGbCtD
Pipotiazine—CYP3A4—Felbamate—epilepsy syndrome	0.00585	0.0169	CbGbCtD
Pipotiazine—CYP1A2—Diazepam—epilepsy syndrome	0.00571	0.0166	CbGbCtD
Pipotiazine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.0055	0.0159	CbGbCtD
Pipotiazine—CYP2D6—Propofol—epilepsy syndrome	0.0052	0.0151	CbGbCtD
Pipotiazine—CYP3A4—Clonazepam—epilepsy syndrome	0.00497	0.0144	CbGbCtD
Pipotiazine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00488	0.0141	CbGbCtD
Pipotiazine—CYP3A4—Clobazam—epilepsy syndrome	0.00477	0.0138	CbGbCtD
Pipotiazine—CYP1A2—Valproic Acid—epilepsy syndrome	0.0045	0.0131	CbGbCtD
Pipotiazine—CYP2C19—Topiramate—epilepsy syndrome	0.0044	0.0128	CbGbCtD
Pipotiazine—CYP3A4—Rufinamide—epilepsy syndrome	0.00405	0.0117	CbGbCtD
Pipotiazine—HTR2A—phrenic nerve—epilepsy syndrome	0.00396	0.112	CbGeAlD
Pipotiazine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00395	0.0114	CbGbCtD
Pipotiazine—CYP3A4—Primidone—epilepsy syndrome	0.00369	0.0107	CbGbCtD
Pipotiazine—CYP3A4—Phenytoin—epilepsy syndrome	0.00354	0.0103	CbGbCtD
Pipotiazine—CYP3A4—Propofol—epilepsy syndrome	0.0033	0.00957	CbGbCtD
Pipotiazine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00316	0.00915	CbGbCtD
Pipotiazine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00316	0.00915	CbGbCtD
Pipotiazine—CYP3A4—Midazolam—epilepsy syndrome	0.00311	0.00902	CbGbCtD
Pipotiazine—CYP3A4—Diazepam—epilepsy syndrome	0.00299	0.00867	CbGbCtD
Pipotiazine—CYP3A4—Zonisamide—epilepsy syndrome	0.00292	0.00847	CbGbCtD
Pipotiazine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00236	0.00684	CbGbCtD
Pipotiazine—DRD1—telencephalic ventricle—epilepsy syndrome	0.00215	0.0608	CbGeAlD
Pipotiazine—CYP3A4—Topiramate—epilepsy syndrome	0.00213	0.00617	CbGbCtD
Pipotiazine—HTR2A—locus ceruleus—epilepsy syndrome	0.00177	0.0499	CbGeAlD
Pipotiazine—HTR2A—cerebellar cortex—epilepsy syndrome	0.00144	0.0407	CbGeAlD
Pipotiazine—HTR1A—telencephalic ventricle—epilepsy syndrome	0.00141	0.0397	CbGeAlD
Pipotiazine—HTR2A—vagus nerve—epilepsy syndrome	0.00135	0.0382	CbGeAlD
Pipotiazine—DRD1—ganglion—epilepsy syndrome	0.00134	0.0378	CbGeAlD
Pipotiazine—DRD2—telencephalic ventricle—epilepsy syndrome	0.00127	0.0359	CbGeAlD
Pipotiazine—SLC22A1—ganglion—epilepsy syndrome	0.00106	0.0299	CbGeAlD
Pipotiazine—HTR2A—pons—epilepsy syndrome	0.00102	0.0288	CbGeAlD
Pipotiazine—HTR2A—autonomic nervous system—epilepsy syndrome	0.00094	0.0265	CbGeAlD
Pipotiazine—HTR1A—ganglion—epilepsy syndrome	0.000877	0.0247	CbGeAlD
Pipotiazine—HTR2A—telencephalic ventricle—epilepsy syndrome	0.000839	0.0237	CbGeAlD
Pipotiazine—DRD2—ganglion—epilepsy syndrome	0.000792	0.0223	CbGeAlD
Pipotiazine—HTR1A—hindbrain—epilepsy syndrome	0.000665	0.0188	CbGeAlD
Pipotiazine—DRD2—hindbrain—epilepsy syndrome	0.000601	0.0169	CbGeAlD
Pipotiazine—DRD1—brainstem—epilepsy syndrome	0.000583	0.0164	CbGeAlD
Pipotiazine—DRD1—forebrain—epilepsy syndrome	0.000562	0.0159	CbGeAlD
Pipotiazine—HTR2A—ganglion—epilepsy syndrome	0.000522	0.0147	CbGeAlD
Pipotiazine—DRD1—telencephalon—epilepsy syndrome	0.000517	0.0146	CbGeAlD
Pipotiazine—SLC22A1—forebrain—epilepsy syndrome	0.000445	0.0126	CbGeAlD
Pipotiazine—SLC22A1—telencephalon—epilepsy syndrome	0.000409	0.0115	CbGeAlD
Pipotiazine—HTR2A—hindbrain—epilepsy syndrome	0.000396	0.0112	CbGeAlD
Pipotiazine—HTR1A—brainstem—epilepsy syndrome	0.000381	0.0107	CbGeAlD
Pipotiazine—DRD1—midbrain—epilepsy syndrome	0.000371	0.0105	CbGeAlD
Pipotiazine—HTR1A—forebrain—epilepsy syndrome	0.000368	0.0104	CbGeAlD
Pipotiazine—CYP2D6—hindbrain—epilepsy syndrome	0.000361	0.0102	CbGeAlD
Pipotiazine—DRD2—brainstem—epilepsy syndrome	0.000344	0.00971	CbGeAlD
Pipotiazine—HTR1A—telencephalon—epilepsy syndrome	0.000338	0.00954	CbGeAlD
Pipotiazine—DRD2—forebrain—epilepsy syndrome	0.000332	0.00937	CbGeAlD
Pipotiazine—DRD1—head—epilepsy syndrome	0.000322	0.00908	CbGeAlD
Pipotiazine—DRD2—telencephalon—epilepsy syndrome	0.000306	0.00862	CbGeAlD
Pipotiazine—DRD1—nervous system—epilepsy syndrome	0.000305	0.00861	CbGeAlD
Pipotiazine—DRD1—central nervous system—epilepsy syndrome	0.000294	0.00829	CbGeAlD
Pipotiazine—SLC22A1—head—epilepsy syndrome	0.000255	0.00719	CbGeAlD
Pipotiazine—HTR1A—midbrain—epilepsy syndrome	0.000243	0.00685	CbGeAlD
Pipotiazine—SLC22A1—nervous system—epilepsy syndrome	0.000242	0.00682	CbGeAlD
Pipotiazine—HTR1A—spinal cord—epilepsy syndrome	0.000237	0.00668	CbGeAlD
Pipotiazine—DRD1—brain—epilepsy syndrome	0.000233	0.00658	CbGeAlD
Pipotiazine—SLC22A1—central nervous system—epilepsy syndrome	0.000233	0.00656	CbGeAlD
Pipotiazine—HTR2A—brainstem—epilepsy syndrome	0.000227	0.00641	CbGeAlD
Pipotiazine—DRD2—midbrain—epilepsy syndrome	0.000219	0.00619	CbGeAlD
Pipotiazine—HTR2A—forebrain—epilepsy syndrome	0.000219	0.00618	CbGeAlD
Pipotiazine—HTR1A—head—epilepsy syndrome	0.000211	0.00594	CbGeAlD
Pipotiazine—CYP2D6—brainstem—epilepsy syndrome	0.000207	0.00584	CbGeAlD
Pipotiazine—HTR2A—telencephalon—epilepsy syndrome	0.000202	0.00569	CbGeAlD
Pipotiazine—CYP2D6—forebrain—epilepsy syndrome	0.0002	0.00563	CbGeAlD
Pipotiazine—HTR1A—nervous system—epilepsy syndrome	0.0002	0.00563	CbGeAlD
Pipotiazine—HTR1A—central nervous system—epilepsy syndrome	0.000192	0.00542	CbGeAlD
Pipotiazine—DRD2—head—epilepsy syndrome	0.00019	0.00537	CbGeAlD
Pipotiazine—HTR1A—cerebellum—epilepsy syndrome	0.000188	0.0053	CbGeAlD
Pipotiazine—SLC22A1—brain—epilepsy syndrome	0.000185	0.00521	CbGeAlD
Pipotiazine—CYP2D6—telencephalon—epilepsy syndrome	0.000184	0.00518	CbGeAlD
Pipotiazine—DRD2—nervous system—epilepsy syndrome	0.00018	0.00509	CbGeAlD
Pipotiazine—ALB—brain—epilepsy syndrome	0.000177	0.00499	CbGeAlD
Pipotiazine—DRD2—central nervous system—epilepsy syndrome	0.000174	0.0049	CbGeAlD
Pipotiazine—DRD2—cerebellum—epilepsy syndrome	0.00017	0.00479	CbGeAlD
Pipotiazine—HTR2A—medulla oblongata—epilepsy syndrome	0.000158	0.00447	CbGeAlD
Pipotiazine—HTR1A—brain—epilepsy syndrome	0.000153	0.0043	CbGeAlD
Pipotiazine—HTR2A—midbrain—epilepsy syndrome	0.000145	0.00408	CbGeAlD
Pipotiazine—HTR2A—spinal cord—epilepsy syndrome	0.000141	0.00398	CbGeAlD
Pipotiazine—DRD2—brain—epilepsy syndrome	0.000138	0.00389	CbGeAlD
Pipotiazine—Imipramine—KCND2—epilepsy syndrome	0.000131	0.0394	CrCbGaD
Pipotiazine—HTR2A—head—epilepsy syndrome	0.000125	0.00354	CbGeAlD
Pipotiazine—HTR2A—nervous system—epilepsy syndrome	0.000119	0.00336	CbGeAlD
Pipotiazine—HTR2A—central nervous system—epilepsy syndrome	0.000115	0.00323	CbGeAlD
Pipotiazine—CYP2D6—head—epilepsy syndrome	0.000114	0.00323	CbGeAlD
Pipotiazine—HTR2A—cerebellum—epilepsy syndrome	0.000112	0.00316	CbGeAlD
Pipotiazine—CYP3A4—nervous system—epilepsy syndrome	0.00011	0.00311	CbGeAlD
Pipotiazine—CYP2D6—nervous system—epilepsy syndrome	0.000108	0.00306	CbGeAlD
Pipotiazine—CYP3A4—central nervous system—epilepsy syndrome	0.000106	0.00299	CbGeAlD
Pipotiazine—CYP2D6—central nervous system—epilepsy syndrome	0.000104	0.00294	CbGeAlD
Pipotiazine—CYP2D6—cerebellum—epilepsy syndrome	0.000102	0.00288	CbGeAlD
Pipotiazine—HTR2A—brain—epilepsy syndrome	9.09e-05	0.00257	CbGeAlD
Pipotiazine—Ethopropazine—CHRM1—epilepsy syndrome	8.52e-05	0.0257	CrCbGaD
Pipotiazine—CYP2D6—brain—epilepsy syndrome	8.28e-05	0.00234	CbGeAlD
Pipotiazine—Cyamemazine—CHRM2—epilepsy syndrome	8.21e-05	0.0247	CrCbGaD
Pipotiazine—Mequitazine—CHRM2—epilepsy syndrome	7.13e-05	0.0215	CrCbGaD
Pipotiazine—Propericiazine—ADRA2A—epilepsy syndrome	7.01e-05	0.0211	CrCbGaD
Pipotiazine—Triflupromazine—CHRM1—epilepsy syndrome	6.98e-05	0.021	CrCbGaD
Pipotiazine—Ethopropazine—CHRM2—epilepsy syndrome	6.96e-05	0.021	CrCbGaD
Pipotiazine—Ethopropazine—BCHE—epilepsy syndrome	5.8e-05	0.0175	CrCbGaD
Pipotiazine—Triflupromazine—CHRM2—epilepsy syndrome	5.7e-05	0.0172	CrCbGaD
Pipotiazine—Propiomazine—CHRM3—epilepsy syndrome	5.54e-05	0.0167	CrCbGaD
Pipotiazine—Propiomazine—CHRM1—epilepsy syndrome	5.16e-05	0.0156	CrCbGaD
Pipotiazine—Zuclopenthixol—ADRA2A—epilepsy syndrome	5.02e-05	0.0151	CrCbGaD
Pipotiazine—Mesoridazine—CHRM2—epilepsy syndrome	5e-05	0.0151	CrCbGaD
Pipotiazine—Prochlorperazine—CHRM2—epilepsy syndrome	4.85e-05	0.0146	CrCbGaD
Pipotiazine—Triflupromazine—BCHE—epilepsy syndrome	4.75e-05	0.0143	CrCbGaD
Pipotiazine—Methotrimeprazine—CHRM3—epilepsy syndrome	4.73e-05	0.0143	CrCbGaD
Pipotiazine—Promethazine—CHRM3—epilepsy syndrome	4.66e-05	0.0141	CrCbGaD
Pipotiazine—Quetiapine—CHRM3—epilepsy syndrome	4.46e-05	0.0134	CrCbGaD
Pipotiazine—Methotrimeprazine—CHRM1—epilepsy syndrome	4.42e-05	0.0133	CrCbGaD
Pipotiazine—Promethazine—CHRM1—epilepsy syndrome	4.35e-05	0.0131	CrCbGaD
Pipotiazine—Thiothixene—ADRA2A—epilepsy syndrome	4.33e-05	0.013	CrCbGaD
Pipotiazine—Propiomazine—CHRM2—epilepsy syndrome	4.22e-05	0.0127	CrCbGaD
Pipotiazine—Quetiapine—CHRM1—epilepsy syndrome	4.16e-05	0.0125	CrCbGaD
Pipotiazine—Cyamemazine—HTR2A—epilepsy syndrome	4.11e-05	0.0124	CrCbGaD
Pipotiazine—Promazine—CHRM3—epilepsy syndrome	4.1e-05	0.0124	CrCbGaD
Pipotiazine—Promazine—CHRM1—epilepsy syndrome	3.83e-05	0.0115	CrCbGaD
Pipotiazine—Thioridazine—CHRM2—epilepsy syndrome	3.78e-05	0.0114	CrCbGaD
Pipotiazine—Thioridazine—HTR7—epilepsy syndrome	3.76e-05	0.0113	CrCbGaD
Pipotiazine—Fluphenazine—ADRA2A—epilepsy syndrome	3.74e-05	0.0113	CrCbGaD
Pipotiazine—Chlorpromazine—CHRM3—epilepsy syndrome	3.61e-05	0.0109	CrCbGaD
Pipotiazine—Methotrimeprazine—CHRM2—epilepsy syndrome	3.61e-05	0.0109	CrCbGaD
Pipotiazine—Imipramine—CHRM3—epilepsy syndrome	3.59e-05	0.0108	CrCbGaD
Pipotiazine—Promethazine—CHRM2—epilepsy syndrome	3.55e-05	0.0107	CrCbGaD
Pipotiazine—Trifluoperazine—CHRM2—epilepsy syndrome	3.5e-05	0.0106	CrCbGaD
Pipotiazine—Perphenazine—HTR7—epilepsy syndrome	3.45e-05	0.0104	CrCbGaD
Pipotiazine—Clomipramine—ADRA2A—epilepsy syndrome	3.42e-05	0.0103	CrCbGaD
Pipotiazine—Quetiapine—CHRM2—epilepsy syndrome	3.4e-05	0.0102	CrCbGaD
Pipotiazine—Quetiapine—HTR7—epilepsy syndrome	3.38e-05	0.0102	CrCbGaD
Pipotiazine—Chlorpromazine—CHRM1—epilepsy syndrome	3.37e-05	0.0101	CrCbGaD
Pipotiazine—Imipramine—CHRM1—epilepsy syndrome	3.35e-05	0.0101	CrCbGaD
Pipotiazine—Mequitazine—CYP2D6—epilepsy syndrome	3.26e-05	0.00983	CrCbGaD
Pipotiazine—Thioridazine—ADRA2A—epilepsy syndrome	3.22e-05	0.00971	CrCbGaD
Pipotiazine—Domperidone—CYP2D6—epilepsy syndrome	3.22e-05	0.00971	CrCbGaD
Pipotiazine—Promazine—CHRM2—epilepsy syndrome	3.12e-05	0.00941	CrCbGaD
Pipotiazine—Methotrimeprazine—ADRA2A—epilepsy syndrome	3.08e-05	0.00927	CrCbGaD
Pipotiazine—Perphenazine—ADRA2A—epilepsy syndrome	2.96e-05	0.00891	CrCbGaD
Pipotiazine—Zuclopenthixol—HTR2A—epilepsy syndrome	2.94e-05	0.00887	CrCbGaD
Pipotiazine—Quetiapine—ADRA2A—epilepsy syndrome	2.9e-05	0.00874	CrCbGaD
Pipotiazine—Chlorpromazine—CHRM2—epilepsy syndrome	2.75e-05	0.00829	CrCbGaD
Pipotiazine—Chlorpromazine—HTR7—epilepsy syndrome	2.74e-05	0.00825	CrCbGaD
Pipotiazine—Imipramine—CHRM2—epilepsy syndrome	2.74e-05	0.00824	CrCbGaD
Pipotiazine—Imipramine—HTR7—epilepsy syndrome	2.72e-05	0.0082	CrCbGaD
Pipotiazine—Zuclopenthixol—CYP2D6—epilepsy syndrome	2.69e-05	0.00811	CrCbGaD
Pipotiazine—Promazine—ADRA2A—epilepsy syndrome	2.67e-05	0.00804	CrCbGaD
Pipotiazine—Acepromazine—HTR2A—epilepsy syndrome	2.64e-05	0.00795	CrCbGaD
Pipotiazine—Clomipramine—SLC6A4—epilepsy syndrome	2.61e-05	0.00786	CrCbGaD
Pipotiazine—Thioproperazine—HTR2A—epilepsy syndrome	2.58e-05	0.00777	CrCbGaD
Pipotiazine—Thiothixene—HTR2A—epilepsy syndrome	2.54e-05	0.00765	CrCbGaD
Pipotiazine—Mesoridazine—HTR2A—epilepsy syndrome	2.5e-05	0.00755	CrCbGaD
Pipotiazine—Clomipramine—CYP2C19—epilepsy syndrome	2.47e-05	0.00746	CrCbGaD
Pipotiazine—Chlorpromazine—ADRA2A—epilepsy syndrome	2.35e-05	0.00707	CrCbGaD
Pipotiazine—Thioridazine—CYP2C19—epilepsy syndrome	2.33e-05	0.00702	CrCbGaD
Pipotiazine—Thiothixene—CYP2D6—epilepsy syndrome	2.32e-05	0.00699	CrCbGaD
Pipotiazine—Domperidone—ABCB1—epilepsy syndrome	2.3e-05	0.00693	CrCbGaD
Pipotiazine—Chlorpromazine—BCHE—epilepsy syndrome	2.29e-05	0.00691	CrCbGaD
Pipotiazine—Mesoridazine—CYP2D6—epilepsy syndrome	2.29e-05	0.0069	CrCbGaD
Pipotiazine—Prochlorperazine—CYP2D6—epilepsy syndrome	2.22e-05	0.00668	CrCbGaD
Pipotiazine—Fluphenazine—HTR2A—epilepsy syndrome	2.19e-05	0.00661	CrCbGaD
Pipotiazine—Perphenazine—CYP2C19—epilepsy syndrome	2.14e-05	0.00645	CrCbGaD
Pipotiazine—Propiomazine—HTR2A—epilepsy syndrome	2.11e-05	0.00636	CrCbGaD
Pipotiazine—Quetiapine—CYP2C19—epilepsy syndrome	2.1e-05	0.00632	CrCbGaD
Pipotiazine—Clomipramine—HTR2A—epilepsy syndrome	2.01e-05	0.00604	CrCbGaD
Pipotiazine—Fluphenazine—CYP2D6—epilepsy syndrome	2.01e-05	0.00604	CrCbGaD
Pipotiazine—Promazine—CYP2C19—epilepsy syndrome	1.93e-05	0.00581	CrCbGaD
Pipotiazine—Thioridazine—HTR2A—epilepsy syndrome	1.89e-05	0.00569	CrCbGaD
Pipotiazine—Triflupromazine—ABCB1—epilepsy syndrome	1.86e-05	0.00561	CrCbGaD
Pipotiazine—Clomipramine—CYP2D6—epilepsy syndrome	1.83e-05	0.00553	CrCbGaD
Pipotiazine—Acepromazine—ALB—epilepsy syndrome	1.81e-05	0.00544	CrCbGaD
Pipotiazine—Methotrimeprazine—HTR2A—epilepsy syndrome	1.8e-05	0.00544	CrCbGaD
Pipotiazine—Imipramine—SLC6A4—epilepsy syndrome	1.78e-05	0.00537	CrCbGaD
Pipotiazine—Promethazine—HTR2A—epilepsy syndrome	1.78e-05	0.00535	CrCbGaD
Pipotiazine—Thioproperazine—ALB—epilepsy syndrome	1.76e-05	0.00532	CrCbGaD
Pipotiazine—Trifluoperazine—HTR2A—epilepsy syndrome	1.75e-05	0.00528	CrCbGaD
Pipotiazine—Thiothixene—ALB—epilepsy syndrome	1.74e-05	0.00523	CrCbGaD
Pipotiazine—Perphenazine—HTR2A—epilepsy syndrome	1.73e-05	0.00523	CrCbGaD
Pipotiazine—Thioridazine—CYP2D6—epilepsy syndrome	1.73e-05	0.00521	CrCbGaD
Pipotiazine—Quetiapine—HTR2A—epilepsy syndrome	1.7e-05	0.00512	CrCbGaD
Pipotiazine—Imipramine—CYP2C19—epilepsy syndrome	1.69e-05	0.00509	CrCbGaD
Pipotiazine—Methotrimeprazine—CYP2D6—epilepsy syndrome	1.65e-05	0.00497	CrCbGaD
Pipotiazine—Promethazine—CYP2D6—epilepsy syndrome	1.62e-05	0.0049	CrCbGaD
Pipotiazine—Perphenazine—CYP2D6—epilepsy syndrome	1.59e-05	0.00478	CrCbGaD
Pipotiazine—Promazine—HTR2A—epilepsy syndrome	1.56e-05	0.00471	CrCbGaD
Pipotiazine—Quetiapine—CYP2D6—epilepsy syndrome	1.56e-05	0.00469	CrCbGaD
Pipotiazine—Fluphenazine—ABCB1—epilepsy syndrome	1.43e-05	0.00432	CrCbGaD
Pipotiazine—Chlorpromazine—HTR2A—epilepsy syndrome	1.38e-05	0.00415	CrCbGaD
Pipotiazine—Clomipramine—ALB—epilepsy syndrome	1.37e-05	0.00414	CrCbGaD
Pipotiazine—Imipramine—HTR2A—epilepsy syndrome	1.37e-05	0.00412	CrCbGaD
Pipotiazine—Clomipramine—ABCB1—epilepsy syndrome	1.31e-05	0.00395	CrCbGaD
Pipotiazine—Chlorpromazine—CYP2D6—epilepsy syndrome	1.26e-05	0.00379	CrCbGaD
Pipotiazine—Imipramine—CYP2D6—epilepsy syndrome	1.25e-05	0.00377	CrCbGaD
Pipotiazine—Promethazine—ABCB1—epilepsy syndrome	1.16e-05	0.0035	CrCbGaD
Pipotiazine—Trifluoperazine—ABCB1—epilepsy syndrome	1.14e-05	0.00345	CrCbGaD
Pipotiazine—Quetiapine—ABCB1—epilepsy syndrome	1.11e-05	0.00335	CrCbGaD
Pipotiazine—Chlorpromazine—ALB—epilepsy syndrome	9.41e-06	0.00284	CrCbGaD
Pipotiazine—Chlorpromazine—ABCB1—epilepsy syndrome	8.98e-06	0.00271	CrCbGaD
Pipotiazine—Imipramine—ABCB1—epilepsy syndrome	8.94e-06	0.00269	CrCbGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	3.43e-06	5.87e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PLCB1—epilepsy syndrome	3.43e-06	5.87e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—S100B—epilepsy syndrome	3.42e-06	5.85e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HTR7—epilepsy syndrome	3.41e-06	5.84e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SOCS3—epilepsy syndrome	3.38e-06	5.79e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	3.38e-06	5.78e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CDC42—epilepsy syndrome	3.38e-06	5.78e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—YWHAZ—epilepsy syndrome	3.36e-06	5.75e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HTR7—epilepsy syndrome	3.35e-06	5.74e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—NGF—epilepsy syndrome	3.32e-06	5.69e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HBEGF—epilepsy syndrome	3.31e-06	5.67e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CYP2D6—epilepsy syndrome	3.29e-06	5.63e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	3.29e-06	5.63e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	3.29e-06	5.63e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	3.27e-06	5.6e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AVP—epilepsy syndrome	3.27e-06	5.6e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—GPX1—epilepsy syndrome	3.26e-06	5.59e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HBEGF—epilepsy syndrome	3.26e-06	5.58e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AKT3—epilepsy syndrome	3.25e-06	5.56e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.25e-06	5.56e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCR5—epilepsy syndrome	3.23e-06	5.53e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CHRM3—epilepsy syndrome	3.23e-06	5.53e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—KCNJ11—epilepsy syndrome	3.23e-06	5.53e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—POMC—epilepsy syndrome	3.23e-06	5.53e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	3.22e-06	5.51e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AKT3—epilepsy syndrome	3.2e-06	5.47e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—POMC—epilepsy syndrome	3.18e-06	5.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—ADAM10—epilepsy syndrome	3.17e-06	5.43e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—HTR2A—epilepsy syndrome	3.16e-06	5.42e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—CCL2—epilepsy syndrome	3.16e-06	5.41e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	3.15e-06	5.4e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ADRA2A—epilepsy syndrome	3.13e-06	5.36e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—ADAM10—epilepsy syndrome	3.12e-06	5.35e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—BCHE—epilepsy syndrome	3.12e-06	5.34e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—CCL2—epilepsy syndrome	3.11e-06	5.32e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ABCG2—epilepsy syndrome	3.11e-06	5.32e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	3.09e-06	5.29e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HES1—epilepsy syndrome	3.09e-06	5.29e-05	CbGpPWpGaD
Pipotiazine—ALB—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	3.09e-06	5.29e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.03e-06	5.2e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CYP2C19—epilepsy syndrome	3.03e-06	5.18e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CYP11A1—epilepsy syndrome	3.01e-06	5.15e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	3.01e-06	5.15e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—FYN—epilepsy syndrome	3.01e-06	5.15e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—TSC2—epilepsy syndrome	3e-06	5.14e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—AGT—epilepsy syndrome	3e-06	5.14e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—S100B—epilepsy syndrome	3e-06	5.14e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—H2AFX—epilepsy syndrome	2.99e-06	5.13e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MEF2C—epilepsy syndrome	2.99e-06	5.12e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—SLC2A1—epilepsy syndrome	2.97e-06	5.09e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SOCS3—epilepsy syndrome	2.97e-06	5.09e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CDC42—epilepsy syndrome	2.96e-06	5.08e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.96e-06	5.07e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—S100B—epilepsy syndrome	2.95e-06	5.06e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	2.95e-06	5.06e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	2.95e-06	5.04e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PLCB1—epilepsy syndrome	2.94e-06	5.04e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—APOE—epilepsy syndrome	2.94e-06	5.03e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—TH—epilepsy syndrome	2.93e-06	5.02e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SOCS3—epilepsy syndrome	2.92e-06	5.01e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CDC42—epilepsy syndrome	2.92e-06	4.99e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.89e-06	4.95e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.89e-06	4.94e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—KDR—epilepsy syndrome	2.88e-06	4.93e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AVP—epilepsy syndrome	2.87e-06	4.91e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—AGT—epilepsy syndrome	2.86e-06	4.9e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—NGF—epilepsy syndrome	2.86e-06	4.89e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.84e-06	4.86e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AVP—epilepsy syndrome	2.82e-06	4.83e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	2.81e-06	4.81e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—APOE—epilepsy syndrome	2.8e-06	4.8e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	2.8e-06	4.79e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCR5—epilepsy syndrome	2.78e-06	4.76e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—PRKCB—epilepsy syndrome	2.77e-06	4.75e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—IL6ST—epilepsy syndrome	2.76e-06	4.73e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.76e-06	4.72e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—HTR2A—epilepsy syndrome	2.72e-06	4.66e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HES1—epilepsy syndrome	2.71e-06	4.65e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—HES1—epilepsy syndrome	2.67e-06	4.57e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	2.67e-06	4.57e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	2.64e-06	4.52e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—FYN—epilepsy syndrome	2.64e-06	4.52e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ABCG2—epilepsy syndrome	2.63e-06	4.51e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—TH—epilepsy syndrome	2.63e-06	4.51e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—H2AFX—epilepsy syndrome	2.63e-06	4.5e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MEF2C—epilepsy syndrome	2.62e-06	4.49e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—FYN—epilepsy syndrome	2.6e-06	4.45e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.59e-06	4.44e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—H2AFX—epilepsy syndrome	2.59e-06	4.43e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ADRA2A—epilepsy syndrome	2.59e-06	4.43e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—TSC2—epilepsy syndrome	2.58e-06	4.42e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	2.58e-06	4.42e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AGT—epilepsy syndrome	2.58e-06	4.42e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—BCHE—epilepsy syndrome	2.57e-06	4.41e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	2.56e-06	4.39e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—SRC—epilepsy syndrome	2.56e-06	4.39e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	2.55e-06	4.36e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	2.54e-06	4.34e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	2.53e-06	4.33e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—APOE—epilepsy syndrome	2.53e-06	4.33e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—POMC—epilepsy syndrome	2.53e-06	4.33e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—NGF—epilepsy syndrome	2.51e-06	4.3e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—VEGFA—epilepsy syndrome	2.5e-06	4.28e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.5e-06	4.27e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.49e-06	4.27e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.49e-06	4.27e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—KDR—epilepsy syndrome	2.48e-06	4.24e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CCL2—epilepsy syndrome	2.47e-06	4.23e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	2.47e-06	4.23e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	2.46e-06	4.2e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—HMOX1—epilepsy syndrome	2.45e-06	4.19e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	2.44e-06	4.18e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	2.43e-06	4.16e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—TH—epilepsy syndrome	2.42e-06	4.14e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—CAT—epilepsy syndrome	2.41e-06	4.13e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—POMC—epilepsy syndrome	2.41e-06	4.12e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	2.4e-06	4.11e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	2.39e-06	4.09e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—PRKCB—epilepsy syndrome	2.38e-06	4.08e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—IL6ST—epilepsy syndrome	2.37e-06	4.07e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—ABCB1—epilepsy syndrome	2.35e-06	4.02e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	2.31e-06	3.95e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	2.3e-06	3.94e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	2.27e-06	3.88e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AGT—epilepsy syndrome	2.27e-06	3.88e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—FGF2—epilepsy syndrome	2.23e-06	3.82e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	2.23e-06	3.82e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	2.23e-06	3.82e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—APOE—epilepsy syndrome	2.22e-06	3.8e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.2e-06	3.76e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—ALB—epilepsy syndrome	2.2e-06	3.76e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	2.19e-06	3.75e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	2.18e-06	3.74e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—GPX1—epilepsy syndrome	2.18e-06	3.74e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—BCHE—epilepsy syndrome	2.18e-06	3.73e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—KDR—epilepsy syndrome	2.17e-06	3.72e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—POMC—epilepsy syndrome	2.17e-06	3.72e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.17e-06	3.71e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	2.14e-06	3.66e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CCL2—epilepsy syndrome	2.13e-06	3.64e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.11e-06	3.61e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	2.09e-06	3.58e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	2.09e-06	3.57e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	2.08e-06	3.56e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—RELA—epilepsy syndrome	2.07e-06	3.55e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.06e-06	3.53e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	2.06e-06	3.52e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.05e-06	3.51e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—TH—epilepsy syndrome	2.05e-06	3.51e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MTOR—epilepsy syndrome	2.03e-06	3.48e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.03e-06	3.48e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	2.02e-06	3.46e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	2.02e-06	3.46e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—CAT—epilepsy syndrome	1.99e-06	3.41e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.98e-06	3.39e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.97e-06	3.37e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	1.96e-06	3.36e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	1.94e-06	3.32e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—PTGS2—epilepsy syndrome	1.92e-06	3.29e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—FGF2—epilepsy syndrome	1.92e-06	3.29e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—AGT—epilepsy syndrome	1.91e-06	3.28e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—POMC—epilepsy syndrome	1.91e-06	3.27e-05	CbGpPWpGaD
Pipotiazine—DRD1—GPCR downstream signaling—AKT1—epilepsy syndrome	1.89e-06	3.23e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	1.88e-06	3.21e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—APOE—epilepsy syndrome	1.88e-06	3.21e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—CASP3—epilepsy syndrome	1.87e-06	3.2e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	1.87e-06	3.2e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	1.84e-06	3.14e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—JUN—epilepsy syndrome	1.82e-06	3.11e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—GPX1—epilepsy syndrome	1.8e-06	3.09e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—RELA—epilepsy syndrome	1.78e-06	3.05e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.78e-06	3.04e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—MMP9—epilepsy syndrome	1.77e-06	3.03e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MTOR—epilepsy syndrome	1.75e-06	2.99e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—AGT—epilepsy syndrome	1.72e-06	2.94e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling by GPCR—AKT1—epilepsy syndrome	1.71e-06	2.93e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	1.71e-06	2.93e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.69e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—CAT—epilepsy syndrome	1.69e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	1.69e-06	2.89e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—APOE—epilepsy syndrome	1.68e-06	2.88e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.68e-06	2.88e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	1.66e-06	2.84e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	1.64e-06	2.81e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—SRC—epilepsy syndrome	1.63e-06	2.79e-05	CbGpPWpGaD
Pipotiazine—HTR1A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.62e-06	2.78e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—POMC—epilepsy syndrome	1.61e-06	2.76e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—CASP3—epilepsy syndrome	1.61e-06	2.75e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.61e-06	2.75e-05	CbGpPWpGaD
Pipotiazine—ALB—Hemostasis—AKT1—epilepsy syndrome	1.59e-06	2.73e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.59e-06	2.72e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—VEGFA—epilepsy syndrome	1.59e-06	2.72e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—TH—epilepsy syndrome	1.58e-06	2.71e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—AGT—epilepsy syndrome	1.58e-06	2.71e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—RELA—epilepsy syndrome	1.57e-06	2.68e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—JUN—epilepsy syndrome	1.56e-06	2.67e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—APOE—epilepsy syndrome	1.55e-06	2.65e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	1.54e-06	2.64e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	1.54e-06	2.63e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—GPX1—epilepsy syndrome	1.53e-06	2.61e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—MMP9—epilepsy syndrome	1.52e-06	2.6e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	1.51e-06	2.59e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling by GPCR—AKT1—epilepsy syndrome	1.47e-06	2.52e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.45e-06	2.48e-05	CbGpPWpGaD
Pipotiazine—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	1.43e-06	2.44e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	1.41e-06	2.42e-05	CbGpPWpGaD
Pipotiazine—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.4e-06	2.4e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—SRC—epilepsy syndrome	1.4e-06	2.4e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	1.39e-06	2.38e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—JUN—epilepsy syndrome	1.37e-06	2.35e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—VEGFA—epilepsy syndrome	1.36e-06	2.34e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	1.35e-06	2.31e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—AGT—epilepsy syndrome	1.34e-06	2.29e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	1.33e-06	2.28e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—POMC—epilepsy syndrome	1.33e-06	2.28e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.32e-06	2.26e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.32e-06	2.26e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	1.31e-06	2.25e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—APOE—epilepsy syndrome	1.31e-06	2.25e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.3e-06	2.23e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	1.29e-06	2.22e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—PTGS2—epilepsy syndrome	1.29e-06	2.2e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.27e-06	2.18e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.27e-06	2.17e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—SRC—epilepsy syndrome	1.23e-06	2.11e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—ALB—epilepsy syndrome	1.21e-06	2.08e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	1.21e-06	2.07e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	1.2e-06	2.05e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.18e-06	2.02e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.18e-06	2.02e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.15e-06	1.98e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—POMC—epilepsy syndrome	1.13e-06	1.93e-05	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	1.06e-06	1.82e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.03e-06	1.77e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—ALB—epilepsy syndrome	1.03e-06	1.76e-05	CbGpPWpGaD
Pipotiazine—DRD1—Signaling Pathways—AKT1—epilepsy syndrome	1.01e-06	1.73e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.01e-06	1.73e-05	CbGpPWpGaD
Pipotiazine—SLC22A1—Metabolism—AKT1—epilepsy syndrome	9.66e-07	1.65e-05	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	8.99e-07	1.54e-05	CbGpPWpGaD
Pipotiazine—HTR1A—Signaling Pathways—AKT1—epilepsy syndrome	8.71e-07	1.49e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—POMC—epilepsy syndrome	8.7e-07	1.49e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—ALB—epilepsy syndrome	7.93e-07	1.36e-05	CbGpPWpGaD
Pipotiazine—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	7.64e-07	1.31e-05	CbGpPWpGaD
Pipotiazine—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	7.52e-07	1.29e-05	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	6.94e-07	1.19e-05	CbGpPWpGaD
Pipotiazine—ALB—Metabolism—AKT1—epilepsy syndrome	6.46e-07	1.11e-05	CbGpPWpGaD
Pipotiazine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	5.8e-07	9.93e-06	CbGpPWpGaD
Pipotiazine—CYP2D6—Metabolism—AKT1—epilepsy syndrome	5.33e-07	9.13e-06	CbGpPWpGaD
Pipotiazine—CYP1A2—Metabolism—AKT1—epilepsy syndrome	4.52e-07	7.74e-06	CbGpPWpGaD
Pipotiazine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	3.49e-07	5.97e-06	CbGpPWpGaD
